Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS INC | $7.84 | $4.45 | 76.11% | 130.67x | -24.02x | 6.01x | 7.17x | 0.67x | -$150.00k | -0.03% | $106.03M | 1.19 | $724.06M | 56.39 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.62 | $41.44 | 26.97% | 131.55x | 13.26x | 14.04x | 6.04x | 0.47x | $46.73M | 1.75% | $450.12M | 8.86 | $2.70B | 93.10 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.79 | $18.73 | -47.74% | 6.99x | 19.75x | 5.09x | 3.72x | 0.31x | -$1.99M | -0.37% | $154.66M | 2.80 | $575.59M | 5.80 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $339.41 | $79.98 | 324.35% | 142.01x | 49.73x | 11.97x | 57.04x | 1.79x | $465.38M | 1.05% | $789.18M | 6.02 | $46.33B | 73.36 | ||
| ADMA | ADMA BIOLOGICS INC | $10.49 | $11.69 | -10.23% | 16.92x | 10.77x | 4.90x | 5.23x | 0.45x | $27.82M | 1.12% | $477.32M | 2.00 | $2.48B | 12.55 | ||
| CORT | CORCEPT THERAPEUTICS INC | $43.68 | $20.75 | 110.49% | 45.98x | 80.50x | 5.96x | 7.17x | 1.00x | $141.79M | 3.13% | $647.81M | 6.24 | $4.53B | 100.25 | ||
| HALO | HALOZYME THERAPEUTICS INC | $67.31 | $70.54 | -4.58% | 25.50x | 8.23x | 5.78x | 162.73x | 0.42x | $644.59M | 7.99% | $48.81M | 0.41 | $9.95B | 17.36 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $46.92 | $16.25 | 188.73% | 58.65x | 42.53x | 5.14x | 6.33x | 1.40x | $136.42M | 3.92% | $567.61M | 7.65 | $3.43B | 36.51 | ||
| KRYS | KRYSTAL BIOTECH INC | $270.00 | $109.14 | 147.39% | 38.14x | 34.68x | 20.08x | 6.47x | 1.36x | $189.35M | 2.42% | $1.22B | 42.14 | $7.41B | 37.78 | ||
| RPRX | ROYALTY PHARMA PLC | $48.82 | $41.91 | 16.50% | 27.27x | 9.45x | 8.82x | 2.90x | 0.54x | $2.22B | 10.57% | $9.71B | 22.60 | $36.49B | 33.83 | ||
| VCEL | VERICEL CORP | $35.14 | $8.50 | 313.50% | 106.48x | 79.65x | 6.40x | 5.03x | 1.86x | $24.75M | 1.40% | $354.64M | 7.05 | $1.78B | 51.00 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.69 | $3.36 | 39.38% | 21.32x | 16.87x | 2.87x | 4.91x | 0.77x | $13.21M | 3.56% | $76.53M | 0.97 | $313.61M | 15.97 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.29 | $36.28 | -19.26% | 10.61x | 7.98x | 1.94x | 1.95x | 0.49x | $347.89M | 20.66% | $870.22M | 15.14 | $1.11B | 4.33 | ||
| TECH | BIO-TECHNE CORP | $58.66 | $15.63 | 275.29% | 112.81x | 29.00x | 7.52x | 4.56x | 1.62x | $223.02M | 2.44% | $2.01B | 12.90 | $9.36B | 41.32 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.47 | $47.35 | 17.16% | 30.48x | 12.69x | 3.30x | 1.75x | 0.53x | $724.96M | 6.81% | $6.09B | 31.74 | $9.95B | 17.37 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.85 | $5.09 | 703.08% | 226.94x | -34.63x | 5.13x | 14.11x | 3.52x | $45.01M | 0.87% | $370.15M | 2.93 | $5.23B | 74.70 | ||
| MNKD | MANNKIND CORP | $2.74 | $1.08 | 154.42% | 137.00x | 314.94x | 2.40x | -16.55x | 1.00x | $13.69M | 1.64% | -$51.02M | -0.17 | $1.37B | 25.96 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $232.34 | $110.09 | 111.04% | 36.08x | 24.24x | 16.76x | 4.55x | 1.10x | $48.09M | 1.07% | $1.02B | 52.60 | $4.91B | 24.62 | ||
| EXEL | EXELIXIS INC | $45.86 | $35.45 | 29.37% | 15.92x | 14.35x | 5.37x | 5.51x | 0.83x | $875.84M | 7.03% | $2.16B | 7.96 | $11.60B | 11.67 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $444.28 | $187.64 | 136.77% | 28.74x | 22.81x | 9.47x | 6.05x | 1.54x | $3.19B | 2.81% | $18.67B | 73.00 | $109.62B | 22.53 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $26.19 | $14.96 | 75.09% | 14.97x | 13.66x | 5.44x | 3.35x | 1.75x | $208.61M | 6.51% | $954.27M | 7.80 | $2.49B | 7.75 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $755.51 | $442.63 | 70.69% | 17.54x | 16.12x | 5.51x | 2.56x | 1.31x | $4.08B | 5.16% | $31.26B | 298.82 | $79.46B | 13.66 | ||
| INCY | INCYTE CORP | $97.69 | $68.26 | 43.11% | 14.82x | 12.62x | 3.71x | 3.76x | 1.08x | $1.35B | 7.10% | $5.17B | 26.47 | $16.38B | 9.30 | ||
| UTHR | UNITED THERAPEUTICS CORP | $578.54 | $269.06 | 115.02% | 19.20x | 19.79x | 8.05x | 3.57x | 2.00x | $1.04B | 4.06% | $7.10B | 160.19 | $23.80B | 13.08 | ||
| VCYT | VERACYTE INC | $34.30 | $10.32 | 232.46% | 40.83x | 32.36x | 5.21x | 2.08x | 2.14x | $126.63M | 4.70% | $1.31B | 16.67 | $2.40B | 25.93 | ||
| XOMA | XOMA ROYALTY CORP | $39.41 | $10.06 | 291.93% | 25.76x | 80.49x | 9.13x | 5.59x | 8.76x | -$1.83M | -0.38% | $83.94M | 6.95 | $512.41M | 14.77 | ||
| MDXG | MIMEDX GROUP INC | $3.92 | $1.89 | 107.78% | 11.88x | 34.94x | 1.38x | 2.27x | 22.99x | $72.97M | 12.60% | $256.55M | 1.74 | $434.23M | 5.46 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.57 | $3.93 | 92.81% | 12.21x | 18.55x | 1.66x | 2.95x | 5.40x | $41.73M | 11.02% | $130.34M | 2.61 | $381.96M | 7.16 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.